Related Experiment Video
Updated: Sep 14, 2025
Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
Deciphering Depigmentation: Mouse Models for Vitiligo Research
Tyler J Long1, Todd F Pearson2, John E Harris2
1Department of Dermatology, UMass Chan Medical School, Worcester, Massachusetts, USA; Department of Immunology, Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School, Worcester, Massachusetts, USA.
Abstract:
Vitiligo is an autoimmune skin disease characterized by melanocyte loss and skin depigmentation. Although significant advances have been made in understanding the pathogenesis of vitiligo, the development of novel treatments has depended and will likely continue to depend on preclinical animal model research. This review provides a comprehensive overview of established mouse models for vitiligo, categorizing them on the basis of their mechanisms of melanocyte loss, immune involvement, and relevance to human disease. Finally, we explore emerging areas in vitiligo research, emphasizing the need for refined models that better replicate human disease heterogeneity and therapeutic responses. By critically evaluating available mouse models, this review aims to guide researchers in selecting appropriate models to advance vitiligo research and treatment development.
Insights
This review examines mouse models for vitiligo, an autoimmune skin disease causing depigmentation. Understanding these models is crucial for developing new vitiligo treatments and advancing research.
Area of Science:
- Dermatology
- Immunology
- Genetics
Background:
- Vitiligo is an autoimmune skin disease causing melanocyte loss and depigmentation.
- Preclinical animal models are essential for understanding vitiligo pathogenesis and developing treatments.
Purpose of the Study:
- To provide a comprehensive overview of established mouse models for vitiligo.
- To categorize these models based on mechanisms of melanocyte loss, immune involvement, and human disease relevance.
- To explore emerging research areas and the need for refined models.
Main Methods:
- Literature review of established vitiligo mouse models.
- Categorization of models based on disease mechanisms and relevance.
- Critical evaluation of existing models for research application.
Main Results:
- Established mouse models vary in their mechanisms of melanocyte loss and immune involvement.
- Current models offer insights into vitiligo pathogenesis but have limitations in replicating human disease heterogeneity.
- Emerging research highlights the need for more sophisticated models.
Conclusions:
- Selection of appropriate mouse models is critical for advancing vitiligo research.
- Refined models are needed to better mimic human vitiligo and predict therapeutic responses.
- Continued development of preclinical models will drive novel treatment strategies.
